Allscripts Healthcare Solutions (MDRX) Financials
$4.81
As on 04-Sep-2026 09:30EDT
Market cap
$517 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Income Statement ($ Mln) |
Dec-24 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
588.02
|
588.02
|
577.43
|
1,502.70
|
1,632.61
|
1,749.96
|
|||||
|
Cost of Revenue
|
279.60
|
279.60
|
319.27
|
937.01
|
1,058.10
|
1,025.42
|
|||||
|
Gross Profit
|
308.42
|
308.42
|
258.15
|
565.70
|
574.51
|
724.54
|
|||||
|
Operating Expenses
|
335.52
|
607.57
|
182.48
|
596.00
|
674.28
|
746.00
|
|||||
|
Operating Profit (EBIT)
|
-27.10
|
-19.55
|
75.67
|
-57.66
|
-99.69
|
-95.05
|
|||||
|
Other Income
|
--
|
--
|
97.79
|
17.25
|
-138.24
|
172.59
|
|||||
|
Profit before Tax
|
-63.85
|
-63.85
|
157.71
|
-149.31
|
-281.75
|
-62.20
|
|||||
|
Provision for Tax
|
-43.81
|
--
|
27.85
|
-16.69
|
-43.34
|
-18.98
|
|||||
|
Profit after Tax (Net Income)
|
-86.46
|
-86.46
|
134.44
|
700.41
|
-182.18
|
363.74
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
-0.42
|
-4.53
|
|||||
|
Consolidated Profit
|
--
|
--
|
134.44
|
700.41
|
-182.18
|
363.74
|
Liabilities ($ Mln) |
Dec-24 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,017.51
|
1,017.51
|
1,408.14
|
1,666.24
|
1,285.19
|
1,580.40
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
29.31
|
|||||
|
Non-Current Liabilities
|
256.90
|
256.90
|
470.00
|
316.60
|
709.80
|
803.40
|
|||||
|
Current Liabilities
|
230.31
|
230.31
|
488.42
|
934.78
|
1,210.69
|
797.70
|
|||||
|
Total Liabilities
|
1,504.72
|
1,504.72
|
2,425.23
|
2,917.62
|
3,205.74
|
3,181.50
|
Assets ($ Mln) |
Dec-24 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
825.07
|
825.07
|
1,661.81
|
1,764.40
|
2,364.48
|
2,322.50
|
|||||
|
Current Assets
|
679.65
|
679.65
|
761.34
|
1,153.22
|
841.26
|
859.00
|
|||||
|
Total Assets
|
1,504.72
|
1,504.72
|
2,425.20
|
2,917.62
|
3,205.74
|
3,181.50
|
|||||
|
Total Debt*
|
219.44
|
--
|
372.95
|
283.31
|
1,031.39
|
669.41
|
|||||
|
Net Current Assets
|
--
|
449.34
|
214.26
|
218.45
|
-369.43
|
61.24
|
Cashflow ($ Mln) |
Dec-24 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
115.56
|
115.56
|
-75.43
|
-106.72
|
46.25
|
67.90
|
|||||
|
Cash Flow from Investing Activities
|
585.15
|
--
|
-12.18
|
1,615.19
|
-161.06
|
248.01
|
|||||
|
Cash from Financing Activities
|
-444.91
|
-444.91
|
-258.87
|
-1,109.76
|
67.34
|
-293.00
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
-346.47
|
398.71
|
-47.46
|
22.92
|
Financials Ratios |
Dec-24 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-0.67
|
-0.77
|
1.12
|
4.64
|
-1.11
|
2.07
|
|||||
|
Cash EPS ($)
|
-0.67
|
0.26
|
2.59
|
6.06
|
0.29
|
3.17
|
|||||
|
Adjusted Book Value ($)
|
7.89
|
9.08
|
11.72
|
11.05
|
7.82
|
9.01
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
0.90
|
1.03
|
-0.63
|
-0.71
|
0.28
|
0.39
|
|||||
|
Free Cash Flow per Share ($)
|
0.65
|
0.74
|
-0.65
|
-0.82
|
-0.51
|
-0.44
|
Profitability Ratios |
Dec-24 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-6.18
|
7.21
|
32.84
|
-7.98
|
16.88
|
|||||
|
ROE (%)
|
--
|
-7.13
|
8.75
|
47.46
|
-12.71
|
26.93
|
|||||
|
ROA (%)
|
--
|
-4.40
|
5.03
|
22.88
|
-5.70
|
9.82
|
|||||
|
EBIT Margin (%)
|
-9.78
|
--
|
29.55
|
1.45
|
-14.61
|
-0.73
|
|||||
|
Net Margin (%)
|
-14.70
|
-14.70
|
19.91
|
46.08
|
-12.19
|
18.92
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
Dec-24 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
0.02
|
-0.62
|
-0.08
|
-0.07
|
0.17
|
|||||
|
EBIT Growth (%)
|
--
|
--
|
683.28
|
109.13
|
-1,771.50
|
88.95
|
|||||
|
Net Profit Growth (%)
|
--
|
-164.31
|
-80.81
|
484.46
|
-150.08
|
285.15
|
|||||
|
EPS Growth (%)
|
--
|
-1.69
|
-0.76
|
5.19
|
-1.53
|
2.91
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
Dec-24 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
-14.01
|
-22.85
|
16.48
|
3.11
|
-8.86
|
4.65
|
|||||
|
Price / Book Value
|
1.19
|
1.94
|
1.57
|
1.31
|
1.26
|
1.07
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
16.85
|
--
|
9.86
|
17.72
|
209.11
|
12.74
|
|||||
|
Close Price ($)
|
9.40
|
17.64
|
18.45
|
14.44
|
9.82
|
9.64
|
|||||
|
High Price ($)
|
11.80
|
23.25
|
19.01
|
14.91
|
12.40
|
16.13
|
|||||
|
Low Price ($)
|
--
|
13.59
|
13.05
|
4.56
|
8.75
|
8.54
|
|||||
|
Market Cap ($ Cr)
|
--
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
Dec-24 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.22
|
--
|
0.26
|
0.17
|
0.80
|
0.42
|
|||||
|
Short term debt to equity ratio
|
0.01
|
--
|
0.03
|
0.01
|
0.30
|
0.01
|
|||||
|
Current Ratio
|
2.95
|
2.95
|
1.56
|
1.23
|
0.69
|
1.08
|
|||||
|
Quick Ratio
|
--
|
--
|
1.32
|
1.08
|
0.57
|
1.08
|
|||||
|
Interest Coverage
|
-9.05
|
--
|
12.93
|
0.63
|
-5.53
|
-0.25
|
Operating Efficiency Ratios |
Dec-24 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
29.88
|
20.26
|
78.26
|
31.91
|
31.71
|
30.38
|
|||||
|
Asset Turnover
|
--
|
0.30
|
0.22
|
0.49
|
0.51
|
0.47
|
|||||
|
Receivable days
|
91.58
|
177.35
|
294.57
|
121.19
|
117.39
|
106.89
|
|||||
|
Inventory Days
|
--
|
155.19
|
147.64
|
57.16
|
26.57
|
--
|
|||||
|
Payable days
|
40.29
|
24.19
|
24.08
|
27.04
|
30.38
|
28.31
|
|||||
|
Cash Conversion Cycle
|
--
|
308.35
|
418.12
|
151.31
|
113.58
|
78.58
|